Xiangqian Kong

8PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersNeural engineeringEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 26, 2026
Reduced Maintenance DNA Methylation Thresholds Enable Sensitive Reporter Assays for UHRF1 and DNMT1 Inhibition.

Cuicui Xia, Ying Cui, Jiongliang Wang

|Oct 10, 2025
Mapping Context-Aware Phosphosite Regulation of Protein-Protein Interactions Using Deep Learning and Pan-Cancer Proteomics.

Mingyue Cai, Yuqing Xiao, Jiani Zheng

|Mar 21, 2025
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity.

Yao Li, Jiongliang Wang, Linfu Zhou

|Jan 08, 2025
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy.

Wenjing Bai, Jinxin Xu, Wenbin Gu

|Sep 12, 2024
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity.

Yingjie Chang, Huahui Guo, Xue Li

|May 24, 2024
Picrachinentins A-F, 14-Membered Cyclopeptide Alkaloid-Type Burpitides with Uncommon N-Terminal Modifications from Picrasma chinensis and Their Neuroprotective Activity.

Xian-Zhe Fan, Jia-Qi Song, Li-Jun Zhang

Pageof 2

Frequent Collaborators

4 joint publications

Cheng Luo

1 joint publications

Hong Liang

1 joint publications

Hai-Bing Liao

1 joint publications

Hongru Tao